Table 5.
Comparison of AUROC curve values among noninvasive markers for predicting IFG.
| AUROC | 95% confidence interval | Standard error | P value | |
|---|---|---|---|---|
| All | ||||
| FLI | 0.689 | 0.004 | 0.682–0.697 | <0.001 |
| LAP | 0.675 | 0.004 | 0.667–0.683 | <0.001 |
| With fatty liver | ||||
| FLI | 0.609 | 0.006 | 0.598–0.62 | <0.001 |
| LAP | 0.602 | 0.006 | 0.591–0.613 | <0.001 |
| Without fatty liver | ||||
| FLI | 0.669 | 0.006 | 0.656–0.681 | <0.001 |
| LAP | 0.643 | 0.007 | 0.629–0.656 | <0.001 |
| BMI (lean and normal) | ||||
| FLI | 0.673 | 0.008 | 0.658–0.688 | <0.001 |
| LAP | 0.642 | 0.008 | 0.626–0.659 | <0.001 |
| BMI (overweight and obesity) | ||||
| FLI | 0.616 | 0.005 | 0.606–0.627 | <0.001 |
| LAP | 0.605 | 0.005 | 0.595–0.615 | <0.001 |
IFG, impaired fasting glucose; AUROC, area under the receiver operating characteristic; FLI, fatty liver index; LAP, lipid accumulation product; BMI, body mass index.